Borcherding N - Search Results

1

Repurposing Anti-Cancer Drugs for COVID-19 Treatment.

Borcherding N, Jethava Y, Vikas P. Borcherding N, et al. Drug Des Devel Ther. 2020 Nov 18;14:5045-5058. doi: 10.2147/DDDT.S282252. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33239864 Free PMC article. Review.

2

Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer.

Borcherding N, Kolb R, Gullicksrud J, Vikas P, Zhu Y, Zhang W. Borcherding N, et al. J Mol Biol. 2018 Jul 6;430(14):2014-2029. doi: 10.1016/j.jmb.2018.05.030. Epub 2018 May 22. J Mol Biol. 2018. PMID: 29800567 Free PMC article. Review.

3

The clinical promise of immunotherapy in triple-negative breast cancer.

Vikas P, Borcherding N, Zhang W. Vikas P, et al. Among authors: borcherding n. Cancer Manag Res. 2018 Dec 10;10:6823-6833. doi: 10.2147/CMAR.S185176. eCollection 2018. Cancer Manag Res. 2018. PMID: 30573992 Free PMC article. Review.

4

Therapeutic Potential of Combining PARP Inhibitor and Immunotherapy in Solid Tumors.

Vikas P, Borcherding N, Chennamadhavuni A, Garje R. Vikas P, et al. Among authors: borcherding n. Front Oncol. 2020 Apr 28;10:570. doi: 10.3389/fonc.2020.00570. eCollection 2020. Front Oncol. 2020. PMID: 32457830 Free PMC article. Review.

5

Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer.

Maharjan CK, Mo J, Wang L, Kim MC, Wang S, Borcherding N, Vikas P, Zhang W. Maharjan CK, et al. Among authors: borcherding n. Cancers (Basel). 2021 Dec 31;14(1):206. doi: 10.3390/cancers14010206. Cancers (Basel). 2021. PMID: 35008370 Free PMC article. Review.

6

ROR1, an embryonic protein with an emerging role in cancer biology.

Borcherding N, Kusner D, Liu GH, Zhang W. Borcherding N, et al. Protein Cell. 2014 Jul;5(7):496-502. doi: 10.1007/s13238-014-0059-7. Epub 2014 Apr 22. Protein Cell. 2014. PMID: 24752542 Free PMC article. Review.

7

Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies.

Swami U, Chennamadhavuni A, Borcherding N, Bossler AD, Mott SL, Garje R, Zakharia Y, Milhem M. Swami U, et al. Among authors: borcherding n. Antibiotics (Basel). 2020 Oct 27;9(11):740. doi: 10.3390/antibiotics9110740. Antibiotics (Basel). 2020. PMID: 33120998 Free PMC article.

8

The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent.

Cheng Y, Borcherding N, Ogunsakin A, Lemke-Miltner CD, Gibson-Corley KN, Rajan A, Choi AB, Wongpattaraworakul W, Chan CHF, Salem AK, Weiner GJ, Simons AL. Cheng Y, et al. Among authors: borcherding n. Sci Rep. 2021 Jan 15;11(1):1535. doi: 10.1038/s41598-020-80957-z. Sci Rep. 2021. PMID: 33452311 Free PMC article.

9

Transcriptome analysis of basal and luminal tumor-initiating cells in ErbB2-driven breast cancer.

Borcherding N, Bormann N, Kusner D, Kolb R, Zhang W. Borcherding N, et al. Genom Data. 2015 Jun 1;4:119-122. doi: 10.1016/j.gdata.2015.04.008. Genom Data. 2015. PMID: 26167451 Free PMC article.

10

Obesity-associated NLRC4 inflammasome activation drives breast cancer progression.

Kolb R, Phan L, Borcherding N, Liu Y, Yuan F, Janowski AM, Xie Q, Markan KR, Li W, Potthoff MJ, Fuentes-Mattei E, Ellies LG, Knudson CM, Lee MH, Yeung SJ, Cassel SL, Sutterwala FS, Zhang W. Kolb R, et al. Among authors: borcherding n. Nat Commun. 2016 Oct 6;7:13007. doi: 10.1038/ncomms13007. Nat Commun. 2016. PMID: 27708283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page